Arrowhead Pharmaceuticals Inc. (ARWR) –
-
Turnstone Biologics Appoints William Waddill to its Board of Directors
-
Form SC 13G/A ARROWHEAD PHARMACEUTICAL Filed by: VANGUARD GROUP INC
-
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
-
Form 4 ARROWHEAD PHARMACEUTICAL For: Apr 01 Filed by: Hamilton James C
-
Form 144 ARROWHEAD PHARMACEUTICAL Filed by: Hamilton James C
-
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data
-
Form 4 ARROWHEAD PHARMACEUTICAL For: Mar 18 Filed by: Lu Hongbo
-
Form 8-K ARROWHEAD PHARMACEUTICAL For: Mar 14
-
Form 3 ARROWHEAD PHARMACEUTICAL For: Mar 15 Filed by: Lu Hongbo
-
Form 8-K/A ARROWHEAD PHARMACEUTICAL For: Feb 21
-
Form 4 ARROWHEAD PHARMACEUTICAL For: Mar 06 Filed by: Myszkowski Kenneth Allen
-
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
-
Form 144 ARROWHEAD PHARMACEUTICAL Filed by: Myszkowski Kenneth Allen
-
Arrowhead Pharmaceuticals to Participate in Upcoming March 2024 Conferences
-
Form S-8 ARROWHEAD PHARMACEUTICAL
-
Form DEFA14A ARROWHEAD PHARMACEUTICAL
-
Arrowhead Pharmaceuticals Inc. (ARWR) Appoints Hongbo Lu to its Board
-
Form 8-K ARROWHEAD PHARMACEUTICAL For: Feb 21
-
Form SC 13G/A ARROWHEAD PHARMACEUTICAL Filed by: VANGUARD GROUP INC
-
Arrowhead Pharma (ARWR) PT Raised to $55 at B.Riley
-
Arrowhead Pharma (ARWR) PT Raised to $36 at Morgan Stanley
-
Arrowhead Pharma (ARWR) PT Lowered to $75 at UBS
-
Arrowhead Pharma (ARWR) PT Raised to $34 at Citi
-
Form 10-Q ARROWHEAD PHARMACEUTICAL For: Dec 31
-
Form 8-K ARROWHEAD PHARMACEUTICAL For: Feb 06
-
Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 44c
-
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
-
Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 31 Filed by: Anzalone Christopher Richard
-
Form 144 ARROWHEAD PHARMACEUTICAL Filed by: Anzalone Christopher Richard
-
Form ARS ARROWHEAD PHARMACEUTICAL For: Jan 26
-
Form DEFA14A ARROWHEAD PHARMACEUTICAL
-
Form DEF 14A ARROWHEAD PHARMACEUTICAL For: Jan 26
-
Form SC 13G/A ARROWHEAD PHARMACEUTICAL Filed by: STATE STREET CORP
-
Form SC 13G/A ARROWHEAD PHARMACEUTICAL Filed by: BlackRock Inc.
-
Arrowhead Pharmaceuticals to Webcast Fiscal 2024 First Quarter Results
-
Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 16
-
Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 12 Filed by: Hamilton James C
-
Form 144/A ARROWHEAD PHARMACEUTICAL Filed by: Hamilton James C
-
Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 11 Filed by: GIVEN DOUGLAS B
-
Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 11 Filed by: Ferrari Mauro
-
Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 11 Filed by: Waddill William D.
-
Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 11 Filed by: Vakiener Victoria
-
Form 144 ARROWHEAD PHARMACEUTICAL Filed by: Hamilton James C
-
Form 144 ARROWHEAD PHARMACEUTICAL Filed by: Vakiener Victoria
-
Form 144 ARROWHEAD PHARMACEUTICAL Filed by: Waddill William D.
-
Form 144 ARROWHEAD PHARMACEUTICAL Filed by: Ferrari Mauro
-
Form 144 ARROWHEAD PHARMACEUTICAL Filed by: GIVEN DOUGLAS B
-
Arrowhead Pharma (ARWR) PT Raised to $51 at BofA Securities
-
Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 04 Filed by: Oliver Tracie
Back to ARWR Stock Lookup